PharmaSGP
PharmaSGP
PSG
XETR
20.40
EUR
-23.88%
About
PharmaSGP Holding SE is a Germany based company, which operates as a pharmaceutical company. The Company produces and develops non-chemical and over-the-counter drugs and other healthcare products..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 270 |
| Three Month Average Volume | 11.4K |
| High Low | |
| Fifty-Two Week High | 24.5 EUR |
| Fifty-Two Week Low | 17.7 EUR |
| Fifty-Two Week High Date | 15 Mar 2024 |
| Fifty-Two Week Low Date | 21 Nov 2023 |
| Price and Volume | |
| Current Price | 20.4 EUR |
| Beta | 0 |
| Relative Price Change | |
| Four Week Relative Price Change | -7.50% |
| Thirteen Week Relative Price Change | -10.90% |
| Twenty-Six Week Relative Price Change | -16.44% |
| Fifty-Two Week Relative Price Change | -28.31% |
| Year-to-Date Relative Price Change | -19.67% |
| Price Change | |
| One Day Price Change | -2.86% |
| Thirteen Week Price Change | -8.93% |
| Twenty-Six Week Price Change | -10.92% |
| Five Day Price Change | 0.99% |
| Fifty-Two Week Price Change | -15.00% |
| Year-to-Date Price Change | -9.33% |
| Month-to-Date Price Change | -2.86% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 3.31554 EUR |
| Book Value Per Share (Most Recent Quarter) | 3.72512 EUR |
| Tangible Book Value Per Share (Last Fiscal Year) | -2.19362 EUR |
| Tangible Book Value Per Share (Most Recent Quarter) | -1.63709 EUR |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 2.98891 EUR |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 8.43009 EUR |
| Revenue Per Share (Trailing Twelve Months) | 8.94607 EUR |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 1.36 EUR |
| Dividend Per Share (Trailing Twelve Months) | 1.36 EUR |
| Dividend Per Share (5 Year) | -99999.99 EUR |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 1.36726 EUR |
| Excluding Extraordinary Items (Trailing Twelve Months) | 1.51007 EUR |
| Normalized (Last Fiscal Year) | 1.38793 EUR |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 1.36726 EUR |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 1.51007 EUR |
| Including Extraordinary Items (Last Fiscal Year) | 1.36726 EUR |
| Including Extraordinary Items (Trailing Twelve Months) | 1.51007 EUR |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 3.39994 EUR |
| Cash Per Share (Most Recent Quarter) | 3.85898 EUR |
| Cash Flow Per Share (Last Fiscal Year) | 2.1424 EUR |
| Cash Flow Per Share (Trailing Twelve Months) | 2.29336 EUR |
| Free Cash Flow Per Share (Trailing Twelve Months) | 1.69644 EUR |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | 0 |
| Cash Flow Revenue (Trailing Twelve Months) | 19 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 22.48% |
| Pretax Margin (Last Fiscal Year) | 21.66% |
| Pretax Margin (5 Year) | 23.36% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 90.64% |
| Gross Margin (Trailing Twelve Months) | 90.93% |
| Gross Margin (5 Year) | 90.20% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 24.37% |
| Operating Margin (Trailing Twelve Months) | 24.48% |
| Operating Margin (5 Year) | 24.84% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 16.22% |
| Net Profit Margin (Trailing Twelve Months) | 16.88% |
| Net Profit Margin (5 Year) | 17.56% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -13.96% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | 19.53% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 25.80% |
| Revenue Growth (3 Year) | 10.78% |
| Revenue Change (Trailing Twelve Months) | 20.19% |
| Revenue Per Share Growth | 10.79% |
| Revenue Growth (5 Year) | 16.92% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 25.88% |
| Total Debt (5 Year) | 171.01% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 60.21% |
| EPS Change (Trailing Twelve Months) | 38.12% |
| EPS Growth (3 Year) | 2.18% |
| EPS Growth (5 Year) | 15.53% |
| EBITDA | |
| EBITDA (5 Year) | 10.80% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -7.78% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | -100,000 |
| Price to Tangible Book (Most Recent Quarter) | -100,000 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 12 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 12 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 27.7M |
| Net Debt (Last Fiscal Year) | 33.2M |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 2 |
| Price to Sales (Trailing Twelve Months) | 2 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 14 |
| PE Normalized (Last Fiscal Year) | 15 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 15 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 36 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 15 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 14 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | 6.67% |
| Current Dividend Yield | 6.67% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 6 |
| Price to Book (Most Recent Quarter) | 5 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 166 |
| Long Term Debt to Equity (Most Recent Quarter) | 147 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 99.53% |
| Payout Ratio (Trailing Twelve Months) | 90.11% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 2 |
| Quick Ratio (Most Recent Quarter) | 2 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | 15 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | 13 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 3 |
| Current Ratio (Most Recent Quarter) | 3 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 19.9M |
| Free Cash Flow (Trailing Twelve Months) | 20.3M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 9 |
| Net Interest Coverage (Trailing Twelve Months) | 12 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 186 |
| Total Debt to Equity (Most Recent Quarter) | 166 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 12.59% |
| Return on Assets (Trailing Twelve Months) | 13.20% |
| Return on Assets (5 Year) | 13.70% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 46.29% |
| Return on Equity (Trailing Twelve Months) | 46.41% |
| Return on Equity (5 Year) | 29.84% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 15.39% |
| Return on Investment (Trailing Twelve Months) | 16.44% |
| Return on Investment (5 Year) | 19.98% |